Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raj M Khandwalla

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 26, 2020
The AWAKE-HF Study: Sacubitril/Valsartan Impact on Daily Physical Activity and Sleep in Heart FailureRaj M Khandwalla, Daniel Grant, Kade Birkeland, et al.
International Journal of Medical Informatics|August 25, 2019
Feasibility of a voice-enabled automated platform for medical data collection: CardioCubeTomasz Jadczyk, Oskar Kiwic, Raj M Khandwalla, et al.
The American Journal of Cardiology|April 27, 2017
Usefulness of Serial Measurements of Inferior Vena Cava Diameter by Vscan<sup>TM</sup> to Identify Patients With Heart Failure at High Risk of HospitalizationRaj M Khandwalla, Kade T Birkeland, Raymond Zimmer, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 22, 2008
Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failureTimothy J Vittorio, Ronald Zolty, Michael E Kasper, et al.
ESC Heart Failure|October 23, 2019
Activity Sensors to Evaluate the Effect of Sacubitril/Valsartan on Quality-of-Life in Heart Failure: rational and design of the AWAKE-HF studyRaj M Khandwalla, Kade Birkeland, J Thomas Heywood, et al.
JMIR Research Protocols|December 22, 2017
Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover TrialKade Birkeland, Raj M Khandwalla, Ilan Kedan, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 26, 2020
The AWAKE-HF Study: Sacubitril/Valsartan Impact on Daily Physical Activity and Sleep in Heart FailureRaj M Khandwalla, Daniel Grant, Kade Birkeland, et al.
International Journal of Medical Informatics|August 25, 2019
Feasibility of a voice-enabled automated platform for medical data collection: CardioCubeTomasz Jadczyk, Oskar Kiwic, Raj M Khandwalla, et al.
The American Journal of Cardiology|April 27, 2017
Usefulness of Serial Measurements of Inferior Vena Cava Diameter by Vscan<sup>TM</sup> to Identify Patients With Heart Failure at High Risk of HospitalizationRaj M Khandwalla, Kade T Birkeland, Raymond Zimmer, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 22, 2008
Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failureTimothy J Vittorio, Ronald Zolty, Michael E Kasper, et al.
ESC Heart Failure|October 23, 2019
Activity Sensors to Evaluate the Effect of Sacubitril/Valsartan on Quality-of-Life in Heart Failure: rational and design of the AWAKE-HF studyRaj M Khandwalla, Kade Birkeland, J Thomas Heywood, et al.
JMIR Research Protocols|December 22, 2017
Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover TrialKade Birkeland, Raj M Khandwalla, Ilan Kedan, et al.
Pageof 1